Tapewire

Nasdaq · USD

ADIL

ADIAL PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
7742
SEC CIK
0001513525
Parsed reports
114

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202610
Jul 202640
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 27, 2020 Filed Mar 30, 2020 13:23 UTC PurchaseCommon Stock 4,644 $1.35 $6,269.40
Disclosure

SEC source: 0001213900-20-007845 · ownership.xml · nonDerivative · entry 6

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Roth IRA FBO James W Newman, Jr.

Disclosed balance after: 14,644

F5 · ownership.nature: James W. Newman is the beneficiary of this Roth IRA.

Read SEC document
March 27, 2020 Filed Mar 30, 2020 13:23 UTC PurchaseCommon Stock 10,000 $1.34 $13,400.00
Disclosure

SEC source: 0001213900-20-007845 · ownership.xml · nonDerivative · entry 2

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Roundtop Limited Partnership, LLP

Disclosed balance after: 13,288

F1 · shares: James W. Newman is the general partner of Roundtop Limited Partnership, LLP.

F1 · price: James W. Newman is the general partner of Roundtop Limited Partnership, LLP.

F1 · ownership.nature: James W. Newman is the general partner of Roundtop Limited Partnership, LLP.

Read SEC document
March 27, 2020 Filed Mar 30, 2020 13:23 UTC PurchaseCommon Stock 5,000 $1.42 $7,100.00
Disclosure

SEC source: 0001213900-20-007845 · ownership.xml · nonDerivative · entry 1

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
March 26, 2020 Filed Mar 27, 2020 06:03 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 12,652 $1.47 $18,598.44
Disclosure

SEC source: 0001213900-20-007568 · ownership.xml · nonDerivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 715,937

F2 · shares: The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
March 25, 2020 Filed Mar 27, 2020 06:03 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 12,348 $1.13 $13,953.24
Disclosure

SEC source: 0001213900-20-007568 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,285

F1 · shares: The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

F1 · price: The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

Read SEC document
March 03, 2020 Filed Mar 6, 2020 00:18 UTC
Goodman TonyDirector
GrantStock Option · Derivative 60,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005539 · ownership.xml · derivative · entry 1

Goodman Tony · CIK 0001717971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 19:20 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
GrantStock Option · Derivative 460,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005545 · ownership.xml · derivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 460,000

Underlying: Common Stock · 460,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 19:20 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
GrantCommon stock 54,167 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-005545 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 690,937

Read SEC document
March 03, 2020 Filed Mar 5, 2020 19:19 UTC
Truluck JosephDirector · Chief Financial Officer
GrantEmployee Stock Option · Derivative 20,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005543 · ownership.xml · derivative · entry 2

Truluck Joseph · CIK 0001718091 · Director · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

Read SEC document
March 03, 2020 Filed Mar 5, 2020 19:19 UTC
Truluck JosephDirector · Chief Financial Officer
GrantCommon stock 27,084 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-005543 · ownership.xml · nonDerivative · entry 1

Truluck Joseph · CIK 0001718091 · Director · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,639

Read SEC document
March 03, 2020 Filed Mar 6, 2020 00:22 UTC GrantStock Option · Derivative 60,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005549 · ownership.xml · derivative · entry 1

Gilliland Robertson H. · CIK 0001718351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-03-02

F1 · shares: These options vest pro rata on a monthly basis over 36 months.

Read SEC document
March 03, 2020 Filed Mar 6, 2020 00:21 UTC
Schuyler KevinDirector · 10% owner
GrantStock Option · Derivative 60,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005547 · ownership.xml · derivative · entry 1

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

Read SEC document
March 03, 2020 Filed Mar 6, 2020 00:19 UTC GrantStock Option · Derivative 60,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005541 · ownership.xml · derivative · entry 1

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

Read SEC document
March 03, 2020 Filed Mar 6, 2020 00:17 UTC GrantStock Option · Derivative 60,000 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001213900-20-005537 · ownership.xml · derivative · entry 1

Anderson J. Kermit · CIK 0001717983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:00 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
SaleCommon Stock 150,000 $1.00 $150,000.00
Disclosure

SEC source: 0001213900-19-026186 · ownership.xml · nonDerivative · entry 3

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · En Fideicomiso De Mi Vida 11/23/2010 (Trust)

Disclosed balance after: 698,336

F2 · ownership.nature: Dr. Johnson is the trustee of each of these trusts.

Read SEC document
October 02, 2019 Filed Oct 4, 2019 17:01 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
GrantCommon Stock 3,187 $0.00 $0.00
Disclosure

SEC source: 0001213900-19-019766 · ownership.xml · nonDerivative · entry 1

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,055

Read SEC document
March 29, 2019 Filed Apr 1, 2019 16:57 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
PurchaseCommon Stock 600 $3.30 $1,978.02
Disclosure

SEC source: 0001213900-19-005524 · ownership.xml · nonDerivative · entry 4

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,868

Read SEC document
March 29, 2019 Filed Apr 1, 2019 16:57 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
PurchaseCommon Stock 2,500 $3.47 $8,669.00
Disclosure

SEC source: 0001213900-19-005524 · ownership.xml · nonDerivative · entry 3

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,268

Read SEC document
March 29, 2019 Filed Apr 1, 2019 16:57 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
PurchaseCommon Stock 30,000 $3.47 $104,154.00
Disclosure

SEC source: 0001213900-19-005524 · ownership.xml · nonDerivative · entry 2

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,768

Read SEC document
March 28, 2019 Filed Apr 1, 2019 16:57 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
PurchaseCommon Stock 40,000 $3.15 $125,808.00
Disclosure

SEC source: 0001213900-19-005524 · ownership.xml · nonDerivative · entry 1

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,768

Read SEC document
March 24, 2019 Filed Mar 26, 2019 09:15 UTC
Johnson Bankole A.Chief Medical Officer · 10% owner
GrantStock Option · Derivative 250,000 $0.00 Strike: $3.01 $0.00
Disclosure

SEC source: 0001213900-19-004830 · ownership.xml · derivative · entry 1

Johnson Bankole A. · CIK 0001718158 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2029-03-23

F1 · shares: These options vest pro rata on a monthly basis over 36 months.

Read SEC document
March 10, 2019 Filed Mar 12, 2019 18:46 UTC
Truluck JosephChief Financial Officer
GrantStock Option · Derivative 180,000 $0.00 Strike: $3.39 $0.00
Disclosure

SEC source: 0001213900-19-004003 · ownership.xml · derivative · entry 1

Truluck Joseph · CIK 0001718091 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2029-03-09

F1 · shares: These options vest pro rata on a monthly basis over 36 months.

Read SEC document
March 10, 2019 Filed Mar 12, 2019 18:45 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
GrantStock Option · Derivative 500,000 $0.00 Strike: $3.39 $0.00
Disclosure

SEC source: 0001213900-19-004001 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2029-03-09

F1 · shares: These options vest pro rata on a monthly basis over 36 months.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 18:05 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
OtherWarrant to purchase common stock · Derivative 36,800 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-015548 · ownership.xml · derivative · entry 3

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,800

Underlying: Common Stock · 36,800 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

F1 · price: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 18:05 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
OtherWarrant to purchase common stock · Derivative 36,800 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015548 · ownership.xml · derivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,800

Underlying: Common Stock · 36,800 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

F1 · price: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 18:05 UTC
Stilley William B. IIIDirector · Chief Executive Officer · 10% owner
OtherWarrant to purchase units · Derivative 36,800 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015548 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Units · 73,600 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

F1 · price: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 18:01 UTC
Johnson Bankole A.Director · 10% owner
OtherWarrant to purchase common stock · Derivative 17,600 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-015546 · ownership.xml · derivative · entry 3

Johnson Bankole A. · CIK 0001718158 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,600

Underlying: Common Stock · 17,600 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

F1 · price: On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 18:01 UTC
Johnson Bankole A.Director · 10% owner
OtherWarrant to purchase common stock · Derivative 17,600 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015546 · ownership.xml · derivative · entry 2

Johnson Bankole A. · CIK 0001718158 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,600

Underlying: Common Stock · 17,600 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

F1 · price: On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 18:01 UTC
Johnson Bankole A.Director · 10% owner
OtherWarrant to purchase units · Derivative 17,600 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015546 · ownership.xml · derivative · entry 1

Johnson Bankole A. · CIK 0001718158 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Units · 35,200 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

F1 · price: On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:49 UTC
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 162,200 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 6

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by MVA 151 Investors LLC

Disclosed balance after: 162,200

Underlying: Common Stock · 162,200 shares

Expires 2023-07-31

F2 · shares: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

F2 · price: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:49 UTC
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 162,200 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 5

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by MVA 151 Investors LLC

Disclosed balance after: 162,200

Underlying: Common Stock · 162,200 shares

Expires 2023-07-31

F2 · shares: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

F2 · price: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:49 UTC
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase units · Derivative 162,200 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 4

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by MVA 151 Investors LLC

Disclosed balance after: 0

Underlying: Units · 324,400 shares

Expires 2023-07-31

F2 · shares: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

F2 · price: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:49 UTC
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 120,000 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 3

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

F1 · price: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:49 UTC
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 120,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 2

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

F1 · price: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:49 UTC
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase units · Derivative 120,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 1

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Units · 240,000 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

F1 · price: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:47 UTC OtherWarrant to purchase common stock · Derivative 92,000 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-015554 · ownership.xml · derivative · entry 6

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by Virga Ventures LLC

Disclosed balance after: 92,000

Underlying: Common Stock · 92,000 shares

Expires 2023-07-31

F2 · shares: On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC.

F2 · price: On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:47 UTC OtherWarrant to purchase common stock · Derivative 92,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015554 · ownership.xml · derivative · entry 5

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by Virga Ventures LLC

Disclosed balance after: 92,000

Underlying: Common Stock · 92,000 shares

Expires 2023-07-31

F2 · shares: On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC.

F2 · price: On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:47 UTC OtherWarrant to purchase units · Derivative 92,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015554 · ownership.xml · derivative · entry 4

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by Virga Ventures LLC

Disclosed balance after: 0

Underlying: Units · 184,000 shares

Expires 2023-07-31

F2 · shares: On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC.

F2 · price: On November 12, 2018, Virga Ventures, LLC exchanged a warrant to purchase 92,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 92,000 shares of common stock. Mr. Newman is the sole member of Virga Ventures, LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:47 UTC OtherWarrant to purchase common stock · Derivative 20,000 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-015554 · ownership.xml · derivative · entry 3

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ivy Cottage Group, LLC

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC.

F1 · price: On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:47 UTC OtherWarrant to purchase common stock · Derivative 20,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015554 · ownership.xml · derivative · entry 2

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ivy Cottage Group, LLC

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC.

F1 · price: On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 23:47 UTC OtherWarrant to purchase units · Derivative 20,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-18-015554 · ownership.xml · derivative · entry 1

Newman James W. Jr. · CIK 0001718364 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ivy Cottage Group, LLC

Disclosed balance after: 0

Underlying: Units · 40,000 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC.

F1 · price: On November 12, 2018, Ivy Cottage Group, LLC exchanged a warrant to purchase 20,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 20,000 shares of common stock. Mr. Newman is the general partner of Ivy Cottage Group, LLC.

Read SEC document
November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 192,600 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 6

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by MVA 151 Investors LLC

Disclosed balance after: 192,600

Underlying: Common Stock · 192,600 shares

Expires 2023-07-31

F2 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

F2 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Read SEC document
November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 192,600 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 5

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by MVA 151 Investors LLC

Disclosed balance after: 192,600

Underlying: Common Stock · 192,600 shares

Expires 2023-07-31

F2 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

F2 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Read SEC document
November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase units · Derivative 192,600 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 4

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Owned by MVA 151 Investors LLC

Disclosed balance after: 0

Underlying: Units · 385,200 shares

Expires 2023-07-31

F2 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

F2 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Read SEC document
November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 89,600 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 3

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,600

Underlying: Common Stock · 89,600 shares

Expires 2023-07-31

F1 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.

F1 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase common stock · Derivative 89,600 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 2

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,600

Underlying: Common Stock · 89,600 shares

Expires 2023-07-31

F1 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.

F1 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.

Read SEC document
November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment
Schuyler KevinDirector · 10% owner
OtherWarrant to purchase units · Derivative 89,600 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 1

Schuyler Kevin · CIK 0001718094 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Units · 179,200 shares

Expires 2023-07-31

F1 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.

F1 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.

Read SEC document
July 31, 2018 Filed Aug 2, 2018 20:06 UTC
Goodman TonyDirector
PurchaseWarrant to purchase common stock · Derivative 7,000 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-010085 · ownership.xml · derivative · entry 2

Goodman Tony · CIK 0001717971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2023-07-31

F1 · shares: On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.

F1 · price: On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.

Read SEC document
July 31, 2018 Filed Aug 2, 2018 20:06 UTC
Goodman TonyDirector
PurchaseCommon Stock 7,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-18-010085 · ownership.xml · nonDerivative · entry 1

Goodman Tony · CIK 0001717971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,755

F1 · shares: On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.

F1 · price: On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.

Read SEC document
July 31, 2018 Filed Aug 2, 2018 16:16 UTC
Truluck JosephChief Financial Officer
ConversionWarrant · Derivative 5,927 Not disclosed Strike: $6.25 Not disclosed
Disclosure

SEC source: 0001213900-18-010099 · ownership.xml · derivative · entry 3

Truluck Joseph · CIK 0001718091 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,927

Underlying: Common Stock · 5,927 shares

Expires 2023-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The 5,927 shares of common stock and a warrant to purchase 5,927 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,980 at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018.

F1 · price: The 5,927 shares of common stock and a warrant to purchase 5,927 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,980 at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.